Company Name, Ticker, Competitors, else..

Zymeworks Inc (ZYME)

Other Ticker:

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry ../Industry/industry_valuation_ttm.php?pb&ind=803"> • Major Pharmaceutical Preparations

Sector • Healthcare

Zymeworks Inc

ZYME's Fundamental analysis

Select the Comparisons :

None ▼

Select the Ratio:

None▼

None ▼

None▼

ZYME Growth rates comparisons

Looking into Zymeworks Inc growth rates, revenue grew by 1761.5 % in IV. Quarter 2022 from the same quarter a year ago. Ranking at No. 126

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -3.82 %

Zymeworks Inc realized net income compared to net loss a year ago in IV. Quarter 2022

• More on ZYME's Growth

ZYME's Valuation comparisons

Zymeworks Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Zymeworks Inc PEG ratio is at -0.07 Company is currently trading with Price to Cash flow multiple of 2.8 in trailing twelve-month period.

Company

9.46

PE TTM

Industry

0.01

PE TTM

Company's Price to Sales ratio is at 1.35.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.46.

• More on ZYME's Valuation

Total Debt (Millions $)	-
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Revenue/Employee (TTM) $	-
Net Income/Employee (TTM) $	-
Receivable Turnover (TTM)	33.98
Tangible Book Value (Per Share $)	6.95

ZYME's Valuation comparisons

Zymeworks Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Zymeworks Inc PEG ratio is at -0.07 Company is currently trading with Price to Cash flow multiple of 2.8 in trailing twelve-month period.

Company

9.46

PE TTM

Industry

0.01

PE TTM

Company's Price to Sales ratio is at 1.35.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.46.

Zymeworks Inc Price to Book Ratio is at 1.13 higher than Indusry Avg. of 0.03, and higher than S&P 500 Avg. of -0.01

• More on ZYME's Valuation

• Market Capitalization (Millions $)	558
• Shares Outstanding (Millions)	65
• Employees	-
• Revenues (TTM) (Millions $)	412
• Net Income (TTM) (Millions $)	124
• Cash Flow (TTM) (Millions $)	199
• Capital Exp. (TTM) (Millions $)	-13
• Total Debt (Millions $)	-
• Dividend TTM ($)	0 $
• Dividend Yield TTM (%)	-
• Revenue/Employee (TTM) $	-
• Net Income/Employee(TTM) $	-
• Receivable Turnover Ratio (TTM)	33.98
• Tangible Book Value (Per Share $)	6.95

• Market Capitalization (Millions $)	558
• Shares Outstanding (Millions)	65
• Employees	-
• Revenues (TTM) (Millions $)	412
• Net Income (TTM) (Millions $)	124
• Cash Flow (TTM) (Millions $)	199
• Capital Exp. (TTM) (Millions $)	-13

ZYME's Profitability Comparisons
Zymeworks Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2022 to 79.35 %. Zymeworks Inc net profit margin of 76.88 % is currently ranking no. 9 in Major Pharmaceutical Preparations industry, ranking no. 20 in Healthcare sector and number 92 in S&P 500.

	*Ratio*
• Capital Ratio (MRQ)	5.7
• Total Debt to Equity (MRQ)	-
• Tangible Leverage Ratio (MRQ)	0.34
• Asset Turnover Ratio (TTM)	0.94
• Inventory Turnover Ratio (TTM)	-

ZYME's Profitability Comparisons

Zymeworks Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2022 to 79.35 %.

Zymeworks Inc net profit margin of 76.88 % is currently ranking no. 9 in Major Pharmaceutical Preparations industry, ranking no. 20 in Healthcare sector and number 92 in S&P 500.

• More on ZYME's Key Ratios


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar FGH's Profile Stock Price FGH's Financials Business Description Fundamentals Charts & Quotes FGH's News Suppliers FGH's Competitors Customers & Markets Economic Indicators FGH's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071